Fortis Advisors, LLC Bausch Health Companies Inc. Transaction History

Fortis Advisors, LLC

  • $130 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$7.06 - $23.63 $21,180 - $70,890
3,000 Added 44.28%
9,775 $82,000
Q1 2022

May 16, 2022
BUY
$21.6 - $27.79 $21,600 - $27,790
1,000 Added 17.32%
6,775 $155,000
Q3 2021

Nov 12, 2021
BUY
$25.04 - $30.06 $19,406 - $23,296
775 Added 15.5%
5,775 $161,000
Q2 2021

Aug 16, 2021
BUY
$27.43 - $32.7 $137,150 - $163,500
5,000 New
5,000 $147,000

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Fortis Advisors, LLC Portfolio

Follow Fortis Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email